Lung SBRT in a Patient With Severe COPD and a Central Tumor
A 74-year-old woman with severe COPD (FEV1 0.9 L, 38% predicted, on home oxygen 2 L/min) has a 3.2 cm biopsy-proven squamous cell carcinoma in the right upper lobe. The tumor is located 1.8 cm from the main bronchus and abuts the mediastinal pleura; there is no nodal or distant disease (T2N0M0). She is not a surgical candidate. The team proposes 60 Gy in 3 fractions with a 4D-CT-based ITV and abdominal compression. The physicist notes that the ITV is 1.4 cm in the craniocaudal direction and that the tumor motion exceeds the planning margin used for the surrounding lung. The radiation oncologist asks whether the fractionation and motion management are appropriate.
1. Evaluate whether 60 Gy in 3 fractions is appropriate for this centrally located tumor, and justify your answer using radiobiology and normal-tissue constraints.
Read the worked answer
60 Gy in 3 fractions is a very high biologically effective dose (BED10 = 60 x (1 + 3/10) = 180 Gy10) and is used for peripheral tumors, but this tumor is centrally located (within 2 cm of the main bronchus and abutting mediastinal pleura). Central tumors treated with 3-fraction SBRT at these doses carry an unacceptable risk of bronchial stenosis, fistula, and fatal hemoptysis; the accepted approach for central tumors is either a more protracted SBRT schedule (e.g., 50-55 Gy in 5 fractions, or 60 Gy in 8 fractions) or conventionally fractionated chemoradiation if the patient can tolerate it.
Radiobiologically, the high dose per fraction increases the BED to late-responding central airway tissues disproportionately, and the alpha/beta for bronchial mucosa and vessel wall is low (~3), so the late BED is even more unfavorable than the tumor BED suggests. The patient's severe COPD and home oxygen further reduce pulmonary reserve, so any airway complication or radiation pneumonitis would be poorly tolerated.
Conclusion: 60 Gy in 3 fractions is not appropriate. Use a 5-8 fraction central-tumor SBRT regimen (e.g., 50 Gy in 5 fractions or 60 Gy in 8 fractions) with strict airway constraints, or consider conventional fractionation.
2. The ITV is 1.4 cm craniocaudally and the tumor motion exceeds the margin used for surrounding lung. How should motion management be adjusted, and what are the trade-offs?
Read the worked answer
A 1.4 cm ITV indicates substantial respiratory motion. Simply expanding the PTV to cover the ITV increases the volume of irradiated lung and the risk of pneumonitis, which is especially important in a patient with FEV1 38% on home oxygen.
Options and trade-offs:
- Abdominal compression: reduces diaphragmatic excursion and therefore ITV size; it is already planned, but it must be verified with a repeat 4D-CT because compression can be ineffective or poorly tolerated in severe COPD. If it reduces the ITV to ~0.5-0.8 cm, it is worthwhile.
- Respiratory gating (end-expiration or end-inspiration): reduces the irradiated volume and allows a smaller ITV, but requires patient cooperation and adds treatment time; in a patient on home oxygen, breath-hold may be poorly tolerated.
- Tumor tracking: best geometric accuracy but requires fiducials or a tracking system and is not universally available.
- Free-breathing ITV with a larger margin: simplest but delivers the most lung dose.
Given her pulmonary reserve, the priority is to minimize the volume of lung receiving low and intermediate doses (V20, V5). Abdominal compression with verification, or gating if tolerated, is preferred. The plan should be evaluated on lung V20 and mean lung dose, not just PTV coverage. If motion cannot be controlled, a more protracted fractionation or a different modality should be considered.